What is Takara Bio Price-to-Operating-Cash-Flow?
As of today (2024-05-22), Takara Bio's share price is 円1092.00.
Takara Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円200.29. Hence, Takara Bio's Price-to-Operating-Cash-Flow Ratio for today is 5.45.
The historical rank and industry rank for Takara Bio's Price-to-Operating-Cash-Flow or its related term are showing as below:
TSE:4974'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.47 Med: 46.89 Max: 178.5
Current: 5.45
During the past 13 years, Takara Bio's highest Price-to-Operating-Cash-Flow Ratio was 178.50. The lowest was 4.47. And the median was 46.89.
Takara Bio's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was 円-13.33.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円200.29.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Takara Bio was 397.70% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 79.90% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 43.10% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.70% per year.
During the past 13 years, Takara Bio's highest 3-Year average Operating Cash Flow per Share Growth Rate was 79.90% per year. The lowest was -11.30% per year. And the median was 10.30% per year.
Takara Bio Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Takara Bio's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takara Bio Price-to-Operating-Cash-Flow Chart
|
Takara Bio Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
53.45 |
42.38 |
25.63 |
38.63 |
5.66 |
|
Takara Bio Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
42.82 |
5.66 |
5.93 |
5.49 |
6.25 |
Competitive Comparison of Takara Bio's Price-to-Operating-Cash-Flow
For the Biotechnology subindustry, Takara Bio's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takara Bio's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Takara Bio's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Takara Bio's Price-to-Operating-Cash-Flow falls into.
Takara Bio Price-to-Operating-Cash-Flow Calculation
Takara Bio's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 1092.00 | / | 200.288 |
| = | 5.45 |
Takara Bio's Share Price of today is 円1092.00.
Takara Bio's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円200.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Takara Bio (TSE:4974) Business Description
Traded in Other Exchanges
Address
Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
Takara Bio (TSE:4974) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4974 has been successfully added to your